Skip to content

Clinical trials

Cardiomyopathy, Dilated trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Dilated Country / region: France Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20115
20133
20141
20151
20161
20171
20182
20203
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status3
Active, not recruiting2
Recruiting2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
French Cardiology Society3
Institut National de la Santé Et de la Recherche Médicale, France3
University Hospital, Bordeaux3
Assistance Publique Hopitaux De Marseille2
Nantes University Hospital2
University Hospital, Montpellier2
Ancora Heart, Inc.1
Bristol-Myers Squibb1
Karim WAHBI1
Universitaire Ziekenhuizen KU Leuven1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Dilated21
Heart Failure8
Cardiomyopathies3
Cardiomyopathy, Hypertrophic3
Coronary Disease3
Brugada Syndrome2
Cardiomyopathy, Restrictive2
Long QT Syndrome2
Polymorphic Catecholaminergic Ventricular Tachycardia2
Arrhythmias, Cardiac1

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.